Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 USD | +0.40% | -1.56% | +8.58% |
Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.58% | 35.67M | |
+33.25% | 699B | |
+24.88% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.08% | 236B | |
+5.05% | 198B | |
-10.35% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- HC Wainwright Adjusts Price Target on VYNE Therapeutics to $28 From $1.50, Maintains Buy Rating